SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-005367
Filing Date
2022-02-04
Accepted
2022-02-04 08:06:13
Documents
15
Period of Report
2022-02-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea154957-8k_somalogic.htm   iXBRL 8-K 47671
2 PRESS RELEASE ISSUED BY SOMALOGIC, INC. ON FEBRUARY 4, 2022 ea154957ex99-1_somalogic.htm EX-99.1 14321
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1982
  Complete submission text file 0001213900-22-005367.txt   290815

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE slgc-20220204.xsd EX-101.SCH 3880
5 XBRL DEFINITION FILE slgc-20220204_def.xml EX-101.DEF 27029
6 XBRL LABEL FILE slgc-20220204_lab.xml EX-101.LAB 37250
7 XBRL PRESENTATION FILE slgc-20220204_pre.xml EX-101.PRE 25651
9 EXTRACTED XBRL INSTANCE DOCUMENT ea154957-8k_somalogic_htm.xml XML 5771
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10065 (212) 474 6724
SomaLogic, Inc. (Filer) CIK: 0001837412 (see all company filings)

IRS No.: 854298912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40090 | Film No.: 22591033
SIC: 8731 Services-Commercial Physical & Biological Research